The objective is to better understand the existing Heart Failure guidelines development process and its implications in clinical practice. It is not to develop new guidelines, but to gather a multidisciplinary panel of leading international experts to discuss the latest evidence, ongoing research and controversial issues that have implications for the development of clinical practice guidelines.

Attendees include industry representatives with interest in clinical trials, product development, market access, guidelines development and implementation, patients’ advocacy specialists, clinical research organizations and payers.

A series of short presentations and discussions with a focus on practical examples, case studies and interactivity between Faculty members.

Educational Objectives 

After attending the HFGF 2023, participants will be able to:
• better understand the guidelines development process including grading and recommendations of available evidence
• assess which criteria must a drug, device of intervention meet to be recommended by heart failure guidelines
• discuss real or hypothetical scenarios leading to recognition in international guidelines
• shape clinical plans and data generation to meet expectations of guideline tasks force and improve patients outcomes

Closed Workshop

(invitation only)
Organized by The Translational Medicine Academy (TMA). A major opportunity to meet a panel of international experts in Heart Failure.

PRACTICAL DETAILS

SCIENTIFIC PROGRAM

TO BETTER UNDERSTAND THE HEART FAILURE GUIDELINES PROCESS AND ITS IMPLICATIONS